HCPCS Level IIdrugActive
J9260
Inj methotrexate sodium 50mg
BETOS: O1D
Effective: 2024-04-01
Referenced in 2 policies
Description
Injection, methotrexate sodium, 50 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Methotrexate Sodium
Manufacturer
Hikma Pharmaceuticals USA Inc.
HCPCS Dosage
50 MG
Billing Units
20.0000
17
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.